NGRC Stock Chart & Stats
$0.04
<$0.01(2.89%)
At close: 4:00 PM EST
$0.04
<$0.01(2.89%)
Day’s Range― - ―
52-Week Range$0.02 - $0.05
Previous CloseN/A
Volume600.00
Average Volume (3M)3.80K
Market Cap
$3.24M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)52.5
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding154,308,000
10 Day Avg. Volume400
30 Day Avg. Volume3,802
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NGRC FAQ
What was National Graphite Corp.’s price range in the past 12 months?
National Graphite Corp. lowest stock price was $0.02 and its highest was $0.05 in the past 12 months.
What is National Graphite Corp.’s market cap?
National Graphite Corp.’s market cap is $3.24M.
When is National Graphite Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were National Graphite Corp.’s earnings last quarter?
Currently, no data Available
Is National Graphite Corp. overvalued?
According to Wall Street analysts National Graphite Corp.’s price is currently Overvalued.
Does National Graphite Corp. pay dividends?
National Graphite Corp. does not currently pay dividends.
What is National Graphite Corp.’s EPS estimate?
National Graphite Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does National Graphite Corp. have?
National Graphite Corp. has 154,308,000 shares outstanding.
What happened to National Graphite Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of National Graphite Corp.?
Currently, no hedge funds are holding shares in NGRC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
National Graphite Corp.
National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Technical Analysis
Tianci International
―
Bolt Projects Holdings
―
―
Agriculture & Natural Solutions Acquisition Corporation Class A
―
―